Brief: Aquestive Therapeutics, Inc. Q3 Income From Operations USD -11.479 Million
05/11/2025 21:01
Nov 05 (Reuters) - Aquestive Therapeutics, Inc. Q3 net income USD -15.446 million. Q3 pretax profit USD -15.446 million Q3 revenue USD 12.807 million vs. IBES estimate USD 12.7 million Q3 adjusted EBITDA USD -8.563 million vs. IBES estimate USD -10.7 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma